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Abstract
Background A recently published score predicts the
occurrence of acute kidney injury (AKI) after liver resec-
tion based on preoperative parameters (chronic renal fail-
ure, cardiovascular disease, diabetes, and alanine-
aminotransferase levels). By inclusion of additional intra-
operative parameters we aimed to develop a new prediction
model.
Methods A series of 549 consecutive patients were
enrolled. The preoperative score and intraoperative
parameters (blood transfusion, hepaticojejunostomy, oli-
guria, cirrhosis, diuretics, colloids, and catecholamine)
were included in a multivariate logistic regression model.
We added the strongest predictors that improved prediction
of AKI compared to the existing score. An internal vali-
dation by fivefold cross validation was performed, fol-
lowed by a decision curve analysis to evaluate unnecessary
special care unit admissions.
Results Blood transfusions, hepaticojejunostomy, and
oliguria were the strongest intraoperative predictors of AKI
after liver resection. The new score ranges from 0 to 64
points predicting postoperative AKI with a probability of
3.5–95 %. Calibration was good in both models (15 %
predicted risk vs. 15 % observed risk). The fivefold cross-
validation indicated good accuracy of the new model (AUC
0.79 (95 % CI 0.73–0.84)). Discrimination was substan-
tially higher in the new model (AUCnew 0.81 (95 % CI
0.76–0.86) versus AUCpreoperative 0.60 (95 % CI
0.52–0.69), p \ 0.001). The new score could reduce up to
84 unnecessary special care unit admissions per 100
patients depending on the decision threshold.
Conclusions By combining three intraoperative parame-
ters with the existing preoperative risk score, a new pre-
diction model was developed that more accurately predicts
postoperative AKI. It may reduce unnecessary admissions
to the special care unit and support management of patients
at higher risk.
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Introduction
The development and validation of a prediction score to
anticipate acute kidney injury (AKI) after liver resection
was recently reported [1]. The initial score was derived
exclusively from parameters available preoperatively such
as pre-existing chronic renal dysfunction, cardiovascular
disease, diabetes, and increased alanine-aminotransferase
levels. The rationale for this strategy was to identify pre-
operatively patients at risk for AKI in order to intraoper-
atively adjust blood pressure and fluid management
accordingly. It may, however, be equally important to
individualize therapy in the postoperative period according
to the risk for AKI, which may require close monitoring
and pre-emptive treatment against AKI in a special care
unit setting, such as an intermediate care or intensive care
unit.
Postoperative AKI occurs not only because of pre-
existing conditions but also as a result of intraoperative
events, particularly unexpected events such as, e.g.,
bleeding and/or prolonged need for colloids[2–6]. It
remains unclear from the previous study [1] and others [7]
whether adding intraoperative parameters may improve the
prediction of postoperative AKI. Additionally, common
metrics for the accuracy of risk scores (predicted vs.
observed risk or area under the curve [AOC]) do not allow
for a straightforward clinical interpretation of the useful-
ness of a risk score [8, 9]. Therefore, our aim was primarily
to assess whether adding intraoperative predictors to our
preoperative risk score improves the prediction of AKI and
secondarily to compare the clinical usefulness of the
existing score with the new prediction score with regard to
postoperative management.
Materials and methods
Study population and design
Consecutive patients undergoing any type of liver surgery
were included between 1 July 2002 and 31 October 2007
from a single tertiary care center (Swiss Hepato-Pancreato-
Biliary (HPB) Centre, University Hospital of Zurich,
Switzerland) identically to the previously published data-
base [1]. All patients with liver trauma and incomplete
intraoperative data sets were excluded. All data were col-
lected and entered into the database of the Swiss HPB
Centre. The study was approved by the institutional review
board for human studies (StV 33-2009) and internationally
registered at clinicaltrials.gov (NCT01318798).
Definition of postoperative AKI
As in the previous study [1], postoperative AKI was
defined according to the ‘‘R’’ of the RIFLE criteria as an
absolute increase in serum creatinine of more than 0.3 mg/
dl above baseline, or an increase [1.5 times the preoper-
ative baseline value within 48 h after surgery [10–14].
Selection criteria of predictors for AKI
Intraoperative strategies may have an impact on the
development of postoperative AKI. Therefore an
improvement of the preoperative prediction score by
intraoperative parameters will already offer the possibility
for intraoperative treatment strategies in patients with
increased risk for AKI. To improve the preoperatively
predicted risk of AKI, intraoperative parameters were
considered that are readily available but that do not have a
strong association among themselves. A priori, the number
of potential intraoperative predictors was restricted to
fewer than ten to minimize the risk of developing overfitted
models that would limit the applicability of the score in
clinical practice.
Seven intraoperative predictive parameters—namely,
the need for blood transfusion (no/yes), the presence of
liver cirrhosis (no/yes), the presences of oliguria (no/yes),
the need for hepaticojejunostomy (no/yes), the use of col-
loids (no/yes), the use of diuretics (no/yes), and the use of a
bolus of catecholamines (no/yes)—were investigated.
Liver cirrhosis was defined as a surgical diagnosis reported
in the operation reports and assured by the histology of an
intraoperative biopsy. Other liver-specific factors, such as
inflow occlusion and operative time, among others, were
not considered as additional parameters in order to prevent
overlapping with other parameters. Oliguria was defined as
an intraoperative urinary output of less than 400 ml/24 h
[8]. The predictive parameter ‘‘diuretics’’ included the
intraoperative use of osmotic or loop diuretics. The pre-
dictor ‘‘bolus of catecholamines’’ was defined as the
intraoperative use of epinephrine, norepinephrine, and/or
dopamine. Predictive parameters like hypotension,
hypovolemia, use of vasopressor infusion, or the total
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123
vasopressor dose were not considered because of a possible
interaction between one of the seven chosen intraoperative
[9, 15–19]. Additionally, predictive parameters such as
mean arterial pressure, total urinary output, total balance,
or operative time were also not considered as additional
parameters in order to prevent overlapping with other
parameters, or because those parameters were not identified
as predictors in the literature of non-cardiac surgery [3].
Statistical analysis
Because the selected predictors are easily available and we
excluded 20 patients with incomplete data sets, no values
for the predictors were missed. The distribution of data was
expressed by using means and standard deviation for nor-
mally distributed data and medians and interquartile ranges
for nonparametric data.
A multivariate logistic regression model was fitted to
predict AKI with the preoperative score (from 0 to 7
points), blood transfusion, cirrhosis, oliguria, hepaticojej-
unostomy, colloids, diuretics, and bolus of catecholamines
as candidate predictors. A stepwise backward logistic
regression model was used to select the strongest predictors
(p \ 0.157) [20]. Bootstrapping was used to repeat the
selection process 549 times (size of the study population)
and retained predictors which were left in the model in
more than 75 % of the bootstrap samples. The shrinkage
was used to reduce the risk of overestimation of the asso-
ciation of the predictors with AKI with the multivariable
logistic regression model [21]. A constant factor (the so-
called Copas factor) was calculated to indicate the degree
of potential overfitting, and all regression coefficients were
multiplied with that factor [21].
For the validation, the AUC was calculated to estimate
how well the new model discriminated between patients
with and without AKI. A model with an AUC of more than
0.7 is generally considered to be a good model [22]. Cal-
ibration was investigated by plotting the observed risk of
AKI against five predicted risk groups of equal size for
AKI and to test the Hosmer–Lemeshow test to see whether
predicted and observed risks differed significantly from
each other, which would indicate poor calibration [23, 24].
Fivefold cross-validation for internal validation was also
performed [23, 25].
Table 1 Patient characteristics
Postoperative normal kidney function
n = 467 (85.1 %)
Postoperative acute kidney injury
n = 82 (14.9 %)
Age, years; median (IQR) 58 (47–65) 67 (58–73)
Gender, male/female (%) 257/210 (55/45) 45/37 54.9 %/45.1 %
Body mass index, kg/m2; median (IQR) 24.6 (22–28) 25 (22–30)
Cardiovascular disease (%)a 43 (9.2) 24 (29.3 %)
Chronic renal failure (%) 43 (9.2 28 (34.1 %)
COPD (%) 23 (4.9) 9 (11 %)
Diabetes (%) 40 (8.6) 19 (23.2 %)
Viral hepatitis (%) 27 (5.8) 12 (14.6 %)
Charlson indexb, mean ± SD 5.0 ± 3.7 5.8 ± 3.1
ASA score; median (IQR) 2 (2–3) 3 (2–3)
B2 (%) 349 (74.7) 39 (47.6 %)
[2 (%) 118 (25.3) 43 (52.4 %)
Benign/malignant disease (%) 128/339 (27.4/72.6) 13/69 (15.9/84.1)
Primary/secondary liver tumor (%) 226/225 (48.4/48.2) 46/31 (56.1/37.8)
Preoperative chemotherapy (%) 183 (39.2) 22 (26.8 %)
Creatinine clearance, ml/h; median (IQR) 85.5 (71.3–106.7) 64.4 (55.2–80.2)
Creatinine, lmol/l; median (IQR) 79 (69–87) 90.5 (77–107)
Bilirubin, lmol/l; median (IQR) 10 (7–14) 13 (10–21)
AST, U/l; median (IQR) 28 (23–45) 37.5 (28–61)
ALT, U/l; median (IQR) 31 (21–53) 43 (24–72.5)
COPD chronic obstructive pulmonary disease; ASA American Society of Anesthesiologists score; IQR interquartile range; ALT alanine-
aminotransferase; AST aspartate-aminotransferase; SD standard deviation
a Cardiovascular disease is defined as the presence of coronary artery disease, previous coronary revascularization, or cerebral arterial occlusive
disease and/or peripheral vascular occlusive disease
b Charslon comorbidity index [34]
Numbers that are given, are numbers of patients unless otherwise stated
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To facilitate the clinical applicability of the new pre-
diction score, we also developed a new point system fol-
lowing an established approach [26]. The regression
coefficients of the predictors were transformed into points
so that they reflected the strengths of association with the
outcome (AKI). The points for each predictor were sum-
med, and we calculated the predicted risk of AKI according
to a standard approach [26].
Finally, we used a theoretical model of decision curve
analysis [27, 28] to compare how in many patients an
unwarranted decision (e.g., unnecessary special care unit
referral because the risk for AKI is very low) can be
avoided by the use of different decision strategies. This is a
theoretical model that may overestimate or even underes-
timate the usefulness of the model because there are other
causes for the need for admission to a special care unit than
Table 2 Intraoperative
parameters of patients
IQR interquartile range, MAP
mean arterial pressure
Numbers that are given, are
numbers of patients unless
otherwise stated
Postoperative
normal
kidney function
n = 467 (85.1 %)
Postoperative
acute
kidney injury
n = 82 (14.9 %)
General
Operative time, min; median (IQR) 275 (205–360) 327.5 (260–450)
Liver resection (%)
Minor 230 (49.3) 29 (35.4 %)
Major 143 (30.6) 31 (37.8 %)
Extended 94 (20.1) 22 (26.8 %)
Pringle maneuver (%) 350 (74.9) 69 (84.1 %)
Pringle time, min; median (IQR) 30 (15–35) 30 (19.5–37.5)
Blood loss, ml; median (IQR) 400 (250–700) 700 (400–1500)
Blood transfusion
Erythrocytes (%) 50 (10.7) 26 (31.7 %)
Fresh frozen plasma (%) 14 (3) 12 (14.6 %)
Thrombocytes (%) 1 (0.2) 2 (2.4 %)
Hepaticojejunostomy (%) 48 (10.3) 24 (29.3 %)
Portal vein ligation (%) 15 (3.2) 0 %
Vessels resected (%)
Portal vein resection (%) 14 (3) 7 (8.5 %)
Hepatic artery resection (%) 3 (0.6) 2 (2.4 %)
Cava vein resection (%) 3 (0.6) 2 (2.4 %)
Hepatic vein resection (%) 1 (0.2) 0 %
Radiofrequency ablation (%) 19 (4.1) 5 (6.1 %)
Cirrhosis (%) 27 (5.8) 10 (12.2 %)
Cryotherapy (%) 6 (1.3) 1 (1.2 %)
Intraoperative blood perfusion outcome
Central venous pressure (mmHg) during Pringle maneuver;
median (IQR)
3 (1–4) 3 (2–6)
Mean MAP (mmHg); median (IQR) 70 (65–75) 70 (65–70)
Lower MAP \ 70 mmHg (%) 447 (95.7 %) 80 (97.6 %)
Number of MAP periods lower than 70 mmHg; median (IQR) 4 (3–6) 5 (4–8)
Minimal MAP, mmHg; median (IQR) 55 (50–60) 55 (50–60)
Catecholamines (%) 429 (91.9) 80 (97.6 %)
Catecholamines bolus dose (%) 281 (60.2) 59 (72 %)
Dosage, lg; median (IQR) 10 (0–40) 30 (0–70)
Catecholamines continuously intravenous; median (IQR) 416 (89.1 %) 78 (95.1 %)
Dosage, lg/h 3.3 (2–5) 4.85 (3.2–6.5)
Minimal dosage, lg/h 0.5 (0–1) 1 (0–1)
Maximal dosage, lg/h 6 (4–10) 10 (7–15)
Length of time, min 270 (175–365) 370 (270–495)
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only AKI. Therefore the threshold at which special care
unit treatment is needed depends much on the judgment of
the physicians and immediate circumstances. For example,
while some physicians in a setting with constrained
resources may only refer patients to a special care unit after
liver resection if the risk is [10 %, other physicians may
be more conservative and refer each patient at risk for AKI
of [5 %. Decision curve analyses compare different
decision strategies and take these potential treatment
thresholds into consideration. In the present study the use
of the preoperative score was compared with the improved
score in order to refer patients to a special care unit, with
additional comparisons to the referral of all or no patients.
Decision curve analysis ultimately tells how in many
patients a wrong decision (e.g., unnecessary special care
unit referral because the risk for AKI is very low) can be
avoided by the use of different decision strategies. In our
study the use of the preoperative score was compared with
the new score in order to refer patients for special care,
with additional comparisons to the referral of all or no
patients.
We used STATA 10 (Stata Corp., College Station, TX)
for the statistical analyses and SPSS (version 19, SPSS inc.,
Chicago, IL) for the graphical presentations.
Results
Study population
A series of 576 consecutive patients were assessed for
eligibility. After exclusion of seven trauma patients and 20
Table 3 Intraoperative kidney
outcome
Total balance of infusion (ml)
means the total amount of
infusions during the whole
surgery. Balance of infusion per
hour (ml/h) means the median
amount of infusion in mL
during one hour of surgery
IQR interquartile range
a Oliguria is a reduction in
urinary output to less than
400 ml/24 h
b Anuria is a reduction in
urinary output to less than
100 ml/24 h
Postoperative normal
kidney function
n = 467 (85.1 %)
Postoperative acute
kidney injury
n = 82 (14.9 %)
Diuresis per hour (ml/h), median (IQR) 111.2 (74.1–172) 93.8 (59.2–156)
Oliguria (%)a 95 (20.3 %) 29 (35.4 %)
Anuria (%)b 21 (4.5 %) 10 (12.2 %)
Diuretics (%) 87 (18.6 %) 26 (31.7 %)
Furosemide (%) 69 (14.8 %) 22 (26.8 %)
Osmotic diuretic (%) 15 (3.2 %) 3 (3.7 %)
Both furosemide and osmotic diuretics (%) 3 (0.6 %) 1 (1.2 %)
Total balance of infusion (ml), median (IQR) 2,020 (1,230–2,960) 2,730 (1,640–4,650)
Balance of infusion per hour (ml/h), median (IQR) 446 (294–665.1) 514.6 (360–773.8)
Colloids (%) 380 (81.4) 75 (91.5 %)
Dosage (ml), median (IQR) 1,000 (500–1,500) 1,000 (750–1,500)
Table 4 Development of the new prediction score based on a multivariate logistic regression model
Predictor Category Odds ratio b
(95 % CI)
Regression
coefficient
b
Shrunken
regression
coefficient bs
p value Reference
value Wi
(midpoint)
bs 9 (Wij -
Wireference)
Risk score
(bs 9 [Wi -
Wireference]/B)
a
Preoperative score 0
1
2
3
4
5
6
7
1.84 (1.55–2.18) 0.609 0.584 \0.001 0 (W1reference)
0.5
1.5
2.5
3.5
4.5
5.5
6.5
0
0.283
0.849
1.415
1.981
2.547
3.113
3.679
0
3
9
15
20
26
32
36
Preoperative score No
Yes
2.68
(1.36–5.30)
0.986 0.946 0.005 0 (W2reference)
1
0
0.946
0
10
Hepaticojejunostomy No
Yes
2.52
(1.32–4.82)
0.925 0.887 0.005 0 (W3reference)
1
0
0.887
0
9
Oliguria No
Yes
2.52
(2.52–4.40)
0.924 0.886 0.001 0 (W4reference)
1
0
0.886
0
9
a Constant B is a coefficient = 0.1; shrinkage coefficient: 0.959
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patients with incomplete data sets, 549 patients were finally
included in the analysis. The frequency of postoperative
AKI was 14.9 % (82 of 549 patients). The overall mor-
bidity was 54.3 % (298 of 549 patients), and 4.2 % of the
patients died within 30 days (23 of 549 patients). Table 1
shows the characteristics of the two groups of patients, with
and without postoperative AKI.
Table 2 demonstrates the intraoperative parameters.
Length of operation was prolonged (median: 328 min
[interquartile range (IQR) 260–450 min] vs. 275 min [IQR
205–360 min]), the extent of resection was larger (38 vs.
31 % major resections), the application of the Pringle
maneuver (inflow occlusion) was more frequent (84 vs.
75 %), and the use of transfusions of blood products was
higher in patients with postoperative AKI compared to
patients without postoperative AKI. In addition, the rates of
hepaticojejunostomy (29 vs. 10 %), vessel resection (13 vs.
4 %), as well as the occurrence of liver cirrhosis identified
intraoperatively by surgeons (12 vs. 6 %) were higher in
patients with AKI. Evaluating intraoperative perfusion
parameters showed that patients with postoperative AKI
received more frequent and higher dosages of catecholamines
than patients with normal postoperative kidney function.
Regarding intraoperative kidney parameters (Table 3), in
patients with postoperative AKI intraoperative diuresis per
hour was lower (median 93.8 ml/h [IQR 59.2–156 ml/h] vs.
111.2 ml/h [IQR 74.1–172 ml/h]), the occurrence of intra-
operative oliguria (36 vs. 20 %) and anuria (12 vs. 4.5 %)
was higher, and the use of diuretics (32 vs. 19 %) was more
frequent than in patients without postoperative AKI.
Table 5 Prediction of risk of acute kidney injury
Risk score based
on 4 predictors
Risk of acute
kidney injury, %
1 3.5
2 3.8
3 4.2
4 4.6
5 5.1
6 5.6
7 6.1
8 6.7
9 7.4
10 8.1
11 8.9
12 9.7
13 10.6
14 11.6
15 12.7
16 13.8
17 15.1
18 16.4
19 17.8
20 19.3
21 20.9
22 22.6
23 24.4
24 26.3
25 28.3
26 30.4
27 32.5
28 34.8
29 37.1
30 39.4
31 41.8
32 44.3
33 46.8
34 49.3
35 51.8
36 54.2
37 56.7
38 59.1
39 61.5
40 63.9
41 66.2
42 68.4
43 70.5
44 72.5
45 74.5
46 76.3
47 78.1
Table 5 continued
Risk score based
on 4 predictors
Risk of acute
kidney injury, %
48 79.7
49 81.3
50 82.8
51 84.2
52 85.4
53 86.6
54 87.8
55 88.8
56 89.8
57 90.6
58 91.5
59 92.2
60 92.9
61 93.5
62 94.1
63 94.6
64 95.1
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Development of the new prediction model
Table 4 presents the multivariate logistic regression model
with the four strongest predictors (preoperative score,
intraoperative blood transfusion [no/yes], hepaticojejunos-
tomy [no/yes], and oliguria [no/yes]) of AKI, and the cor-
responding risk score. All three intraoperative predictors had
the greatest association with postoperative AKI (odds ratio
[OR] for blood transfusion 2.7, for hepaticojejunostomy
[OR = 2.5] and for oliguria [OR = 2.5]) than the preoper-
ative score (OR 1.8). The predictive risk for postoperative
AKI based on the new risk score is summarized in Table 5.
The score ranged from 0 to 64 points, corresponding to a
predictive risk of AKI from 3.5 to 95 %.
Validation of the new prediction model
Discrimination represented by the AUC was higher for the
new prediction model than for the preoperative model (0.81
(95 % confidence interval [CI] 0.76–0.86) vs. 0.60 [95 % CI
0.52–0.69]; p \ 0.001) (Fig. 1). Calibration was good in
both the preoperative model and in the new model, with
predicted risks (15 %) matching with the observed risk
(15 %). The Hosmer–Lemeshow test for the new model
(p = 0.93), as well as for the preoperative score (p = 0.84),
showed a nonsignificant difference between predicted and
observed risks across five risk classes (Fig. 1). The fivefold
cross-validation indicated good internal validity as dis-
crimination (AUC = 0.79 [95 % CI 0.73–0.84]) was only
slightly lower than for the derived model (0.81).
Clinical usefulness of the preoperative and new risk
scores
Table 6 presents the decision curve analysis for referring
patients to a special care unit with regard to the new pre-
diction model compared to the preoperative score, but it
provides a proposition for referring patients to a special care
unit after liver resection. First, the diagram shows that both
prediction scores were clearly better than the strategy that all
patients would be referred to a special care unit following
liver resection. Tables 6 and Appendix in Supplementary
Material. Figure 1 translates the decision curve analysis into
the number of patients, where unnecessary special care unit
treatment could be avoided without missing patients who
need a special care unit admission according to a specific
threshold. The diagram shows that the improved prediction
score, compared with the preoperative score, better
a
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Fig. 1 a Calibration and discrimination plots of the new prediction
score. b. Calibration and discrimination plots of the preoperative
prediction score. The area under the curve (AUC) represents the
discrimination which indicates a better discrimination of patients with
and without AKI by the new prediction model than for the
preoperative model (AUC 0.81 (95 % confidence interval [CI]
0.76–0.86) vs. 0.60 [95 % CI 0.52–0.69]; p \ 0.001)
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discriminates between those who may or need special care
unit care, particularly for low threshold probabilities from 4
to 20 %. For example, with a decision threshold of 6 % for
AKI following liver resection, the clinical use of the new
prediction score would avoid the unnecessary special care
unit admission of 18 % compared to a strategy where all
patients would be referred to a special care unit after surgery.
However, by using the preoperative prediction score, only
7 % of the patients would avoid an unnecessary special care
unit admission. Figure 2 presents the decision curve with all
four treatment strategies.
Discussion
Prediction scores aim to support the decision-making pro-
cess of patients and physicians. They help to allocate
patients to different treatment strategies with the goal of
avoiding under treatment for those who may need more
care and overtreatment for those who require less intensive
care. Our study showed that a prediction score integrating
intraoperative parameters is superior in identifying patients
who would benefit from a special care unit stay in terms of
care for AKI compared to the preoperative prediction score
alone. The use of the new prediction model may likewise
prevent many unnecessary special care unit admissions
following liver resection, particularly for low threshold
probabilities (4–20 %) for AKI. Those results suggest that
the preoperative score should be used for intraoperative
decision making and the full score for admission to a
special care unit for specific protective strategies targeting
the kidney.
Postoperative AKI is known to significantly impair the
outcome after major surgery [29]. Postoperative AKI was
Table 6 Decision curve analysis: calculation of the net benefit for special care unit referrals comparing the preoperative and new prediction
model using threshold probability pt
Threshold
probability,
%
Net benefit
new
prediction
model
Net benefit
preoperative
prediction
model
Net
benefit
treat all
Net benefit
treat none
Net
benefit
new
Net benefit
preoperative
Reducing the number
of unnecessary special
care unit referrals per
100 patients with the
new score
Reducing the number of
unnecessary special care
unit referrals per 100
patients with the
preoperative score
1 0.141 0.141 0.140 0 0.000 0.000 4 4
2 0.132 0.132 0.132 0 0.000 0.000 2 2
3 0.123 0.123 0.123 0 0.000 0.000 1 1
4 0.118 0.114 0.114 0 0.005 0.000 11 1
5 0.113 0.105 0.104 0 0.008 0.000 16 1
6 0.106 0.099 0.095 0 0.012 0.005 18 7
7 0.101 0.095 0.085 0 0.016 0.010 21 13
8 0.097 0.090 0.075 0 0.022 0.015 25 18
9 0.092 0.086 0.065 0 0.027 0.021 28 21
10 0.084 0.083 0.054 0 0.030 0.029 27 26
15 0.071 0.060 -0.001 0 0.072 0.062 41 35
20 0.049 0.041 -0.064 0 0.113 0.104 45 42
25 0.044 0.034 -0.135 0 0.178 0.169 54 51
30 0.034 0.025 -0.216 0 0.250 0.240 58 56
35 0.027 0.019 -0.309 0 0.336 0.328 62 61
40 0.022 0.012 -0.418 0 0.441 0.430 66 65
45 0.020 0.012 -0.547 0 0.567 0.559 69 68
50 0.018 0.009 -0.702 0 0.720 0.711 72 71
55 0.015 0.006 -0.891 0 0.906 0.897 74 73
60 0.017 0.000 -1.128 0 1.145 1.128 76 75
65 0.010 -0.001 -1.431 0 1.441 1.430 78 77
70 0.004 -0.003 -1.837 0 1.841 1.834 79 79
75 0.011 0.002 -2.404 0 2.415 2.406 80 80
80 0.009 0.002 -3.255 0 3.264 3.257 82 81
85 0.004 0.000 -4.673 0 4.677 4.673 83 82
90 0.002 0.000 -7.510 0 7.512 7.510 83 83
95 0.000 0.000 -16.020 0 16.020 16.020 84 84
World J Surg (2013) 37:2618–2628 2625
123
documented in 15 % of the patients following liver resec-
tion, and it significantly correlated not only with increased
mortality compared to patients without postoperative AKI
(23 vs. 0.8 %; p \ 0.001), but also with a prolonged length
of hospital stay (adjusted difference 9.5 days [95 % CI
6.7–12.4]; p \ 0.001) and special care unit stay (adjusted
difference 7.9 days [95 % CI 6.4–9.3]; p \ 0.001) stay. In
the present study, AKI was the main reason for death in
more than half of the patients who died, whereas the sec-
ond most frequent cause of death was infection. Of those
patients who developed an AKI within 48 h after surgery,
72 % fully recovered, whereas 28 % needed postoperative
hemofiltration, and 6 % of that group needed persistent
hemodialysis. Kidney function may have recovered in most
of the patients because of fast and adequate therapy in the
special care unit. Otherwise, we might have observed more
patients requiring postoperative hemofiltrations and per-
sistent hemodialysis.
After a liver resection, the surgeon and anesthesiologist
have to decide whether the patient might benefit from
treatment in a special care unit for the prevention or treat-
ment of AKI. In case of serious comorbidities or intraoper-
ative problems, a special care unit referral decision is easy,
but the difficulty persists with patients who may develop AKI
or other complications. Special care unit referrals are more
expensive than postoperative referral to the ward. Therefore
a reduction of unnecessary special care unit admissions is
economically beneficial and ensures a quieter and more
comfortable recovery for patients. Our improved score also
offers a theoretical tool for special care unit triage, present-
ing a possible decision-making model for postoperative AKI.
It does not inform, however, about the needed length of the
special care unit stay. Further studies have to externally
validate the score and also evaluate the optimal length of
special care unit stay in order to protect the patient with
impaired kidney function from such postoperative risk fac-
tors as low arterial pressure and hypotension by optimizing
fluid management and pain-controlled epidural anesthesia
application. Therefore, a precise triage to a special care unit
after surgery is highly relevant to the patient’s recovery, and
also takes into account the availability of a special care unit
bed and the added health care cost.
We analyzed the clinical consequences of our preopera-
tive score, as well as the new prediction score, by means of a
theoretical model of a decision curve analysis that evaluates
the scores’ clinical usefulness [27, 28, 30]. This goes beyond
the traditional validation of diagnostic and prognostic
models, where typically the accuracy of a model is analyzed.
The interpretation of measures of discrimination and cali-
bration is sometimes not straightforward, and it is difficult to
recognize whether one model offers advantages over
another. Decision analysis goes beyond these measures and
----------- new prediction model with intra-operative predictors
…………….. pre-operative prediction model with pre-operative predictors
-
.
-
.
-
.
- assume all patients go to special care unit peri-operatively 
assume no patients go to special care unit peri-operatively
Fig. 2 Decision curve for special care unit referrals for acute kidney
injury following liver resection. Comparison of four approaches for
decision making in special care unit referrals. The graph presents the
expected net benefit per patient relative to no special care unit
admission of any patients
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evaluates the expected clinical consequences of different
prediction models [27]. The decision curve analysis pre-
sented here suggests that the new prediction score would
theoretically reduce up to 84 unnecessary special care unit
admissions per 100 patients, depending on the decision
threshold, compared to the preoperative prediction score.
Given the substantial potential reduction of unnecessary
special care unit admissions, the additional effort to use the
new prediction score seems to be justified and may reduce
overall costs in the future.
Strengths of the present study are the large sample size
allowing us to update a pre-existing prediction score with
easy and widely available intraoperative predictors. We
internally validated the new prediction score by performing a
k-fold cross-validation [23, 25, 31–33]. Furthermore, the
application of advanced statistical methods, such as shrink-
age, increases the validity and applicability of the prediction
score in other study populations. Another strength is the
decision curve analysis that provides insights into the
potential clinical usefulness of the new risk score.
In contrast, the patient cohort from only a single center
may have to be considered a limitation for generalizability
of this study. Therefore an external validation on geo-
graphically different patient populations is needed for both
scores. A second limitation of this study is that we only
tested one possible clinical strategy (postoperative special
care unit referrals due to increased risk for AKI) and its
consequences and importance by the decision curve anal-
ysis, and that the model may therefore overestimate or even
underestimate the clinical usefulness because there are
many other reasons for an admission to a special care unit.
A third limitation is that we used AKI as the only indica-
tion for postoperative ICU referral rather than multiple
indication outcomes. However, it would require much
larger sample sizes to develop scores that consider multiple
indications as well as their combinations.
In conclusion, we developed a new score to predict the
risk for AKI after liver resection that has the potential to
better support decision making for special care unit referrals,
than using only the preoperative score. Given the substantial
potential reduction of unnecessary special care unit admis-
sions and easy applicability of the new score, the additional
effort to use a risk score postoperatively also seems justified.
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